Table 2.
Gram-negative bacteria pathogens and susceptibility to initial empirical treatment identified in febrile neutropenia patients
| Patients, n (%) | Death, n (%) | Sensitive to initial treatment, n (%) | Confirmed resistance to initial treatment (%) | |
|---|---|---|---|---|
| E. coli | 93 (40.0) | 22 (43.0) | 43 (46.2) | 29 (31.2) |
| K. pneumoniae | 49 (20.0) | 21 (42.9) | 19 (38.8) | 11 (22.4) |
| P. aeruginosa | 27 (11.0) | 7 (25.9) | 15 (55.6) | 2 (7.4) |
| S. maltophilia | 22 (9.0) | 11 (50) | 4 (18.2) | 4 (18.2) |
| E. cloacae | 8 (3.3) | 2 (25) | 1 (12.5) | 4 (50) |
| S. paucimobilis | 7 (2.9) | 0 | 5 (71.4) | 1 (14.3) |
| A. baumannii | 5 (2.0) | 5 (100) | 1 (20) | NA |
| Pantoea | 3 (1.2) | 0 | 1 (33.3) | NA |
| Clostridium falciparum | 2 (0.8) | 1 (50) | 0 | 1 (50) |
| Bacillus cereus | 2 (0.8) | 1 (50) | 0 | NA |
| Burkholderia cepacia | 2 (0.8) | 2 (100) | 0 | NA |